KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dillard'S (DDS) Liabilities and Shareholders Equity (2016 - 2025)

Dillard'S (DDS) has disclosed Liabilities and Shareholders Equity for 17 consecutive years, with $4.3 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Liabilities and Shareholders Equity rose 3.99% year-over-year to $4.3 billion, compared with a TTM value of $15.4 billion through Nov 2025, up 1.58%, and an annual FY2025 reading of $3.5 billion, up 2.38% over the prior year.
  • Liabilities and Shareholders Equity was $4.3 billion for Q4 2025 at Dillard'S, up from $3.7 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $4.3 billion in Q4 2025 and bottomed at $3.1 billion in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $3.6 billion, with a median of $3.7 billion recorded in 2022.
  • Peak annual rise in Liabilities and Shareholders Equity hit 13.13% in 2021, while the deepest fall reached 9.85% in 2021.
  • Year by year, Liabilities and Shareholders Equity stood at $3.7 billion in 2021, then rose by 1.4% to $3.8 billion in 2022, then rose by 2.78% to $3.9 billion in 2023, then grew by 6.03% to $4.1 billion in 2024, then increased by 3.99% to $4.3 billion in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for DDS at $4.3 billion in Q4 2025, $3.7 billion in Q3 2025, and $3.9 billion in Q2 2025.